tiprankstipranks
Trending News
More News >
National Health Investors (NHI)
NYSE:NHI
US Market

National Health Investors (NHI) Ratios

Compare
719 Followers

National Health Investors Ratios

NHI's free cash flow for Q4 2025 was $0.34. For the 2025 fiscal year, NHI's free cash flow was decreased by $ and operating cash flow was $0.48. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
2.48 2.48 0.96 1.16 3.42
Quick Ratio
2.48 2.48 0.96 1.16 3.42
Cash Ratio
0.16 0.16 0.06 0.07 0.17
Solvency Ratio
0.18 0.18 0.17 0.17 0.11
Operating Cash Flow Ratio
1.92 1.92 0.50 0.57 1.65
Short-Term Operating Cash Flow Coverage
1.92 1.92 0.63 0.75 4.41
Net Current Asset Value
$ -946.76M$ -946.76M$ -832.28M$ -839.24M$ -834.51M
Leverage Ratios
Debt-to-Assets Ratio
0.42 0.42 0.44 0.46 0.46
Debt-to-Equity Ratio
0.76 0.76 0.84 0.91 0.90
Debt-to-Capital Ratio
0.43 0.43 0.46 0.48 0.47
Long-Term Debt-to-Capital Ratio
0.41 0.41 0.37 0.42 0.47
Financial Leverage Ratio
1.84 1.84 1.91 1.98 1.97
Debt Service Coverage Ratio
1.66 1.55 0.68 0.86 2.12
Interest Coverage Ratio
4.57 3.40 3.28 3.22 3.13
Debt to Market Cap
0.29 0.33 0.38 0.47 0.49
Interest Debt Per Share
25.72 26.05 27.42 27.44 26.58
Net Debt to EBITDA
4.14 4.06 4.25 4.28 6.31
Profitability Margins
Gross Profit Margin
78.97%36.70%96.67%96.40%96.48%
EBIT Margin
51.73%52.35%57.50%59.37%38.77%
EBITDA Margin
73.43%74.50%78.81%81.25%64.25%
Operating Profit Margin
50.71%51.47%54.85%55.90%47.72%
Pretax Profit Margin
37.41%37.19%40.75%42.02%23.51%
Net Profit Margin
37.78%37.56%41.17%42.41%23.87%
Continuous Operations Profit Margin
37.41%37.19%40.77%42.02%23.55%
Net Income Per EBT
100.99%100.99%101.02%100.95%101.52%
EBT Per EBIT
73.76%72.26%74.29%75.16%49.27%
Return on Assets (ROA)
5.08%5.08%5.28%5.45%2.65%
Return on Equity (ROE)
9.63%9.34%10.10%10.82%5.23%
Return on Capital Employed (ROCE)
7.14%7.29%8.36%8.26%5.54%
Return on Invested Capital (ROIC)
6.82%6.97%7.26%7.42%5.45%
Return on Tangible Assets
5.08%5.08%5.28%5.45%2.65%
Earnings Yield
3.68%3.97%4.54%5.60%2.84%
Efficiency Ratios
Receivables Turnover
1.30 1.30 0.90 0.93 0.87
Payables Turnover
0.00 0.00 0.30 0.34 0.38
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00
Asset Turnover
0.13 0.14 0.13 0.13 0.11
Working Capital Turnover Ratio
1.96 4.51 20.09 1.99 0.78
Cash Conversion Cycle
281.83 280.21 -830.97 -693.18 -548.54
Days of Sales Outstanding
281.83 280.21 403.36 394.37 417.47
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
0.00 0.00 1.23K 1.09K 966.01
Operating Cycle
281.83 280.21 403.36 394.37 417.47
Cash Flow Ratios
Operating Cash Flow Per Share
5.12 5.12 4.74 4.25 4.14
Free Cash Flow Per Share
4.74 4.70 4.65 4.16 4.04
CapEx Per Share
0.38 0.43 0.09 0.09 0.10
Free Cash Flow to Operating Cash Flow
0.93 0.92 0.98 0.98 0.98
Dividend Paid and CapEx Coverage Ratio
1.28 1.27 1.29 1.15 1.11
Capital Expenditure Coverage Ratio
13.49 12.03 51.06 49.28 40.04
Operating Cash Flow Coverage Ratio
0.21 0.21 0.18 0.16 0.16
Operating Cash Flow to Sales Ratio
0.64 0.63 0.62 0.58 0.67
Free Cash Flow Yield
5.57%6.15%6.70%7.46%7.73%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
27.14 25.18 22.02 17.86 35.21
Price-to-Sales (P/S) Ratio
10.60 9.46 9.07 7.58 8.40
Price-to-Book (P/B) Ratio
2.54 2.35 2.22 1.93 1.84
Price-to-Free Cash Flow (P/FCF) Ratio
17.97 16.25 14.92 13.41 12.94
Price-to-Operating Cash Flow Ratio
16.09 14.90 14.62 13.14 12.62
Price-to-Earnings Growth (PEG) Ratio
-5.41 -7.19 68.92 0.04 -0.57
Price-to-Fair Value
2.54 2.35 2.22 1.93 1.84
Enterprise Value Multiple
18.58 16.75 15.75 13.61 19.39
Enterprise Value
5.13B 4.72B 4.16B 3.54B 3.47B
EV to EBITDA
18.58 16.75 15.75 13.61 19.39
EV to Sales
13.64 12.48 12.41 11.06 12.46
EV to Free Cash Flow
23.12 21.45 20.42 19.57 19.18
EV to Operating Cash Flow
21.41 19.66 20.02 19.17 18.70
Tangible Book Value Per Share
32.85 32.85 31.59 29.36 28.81
Shareholders’ Equity Per Share
32.46 32.46 31.17 28.90 28.37
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 >-0.01 0.00 >-0.01
Revenue Per Share
8.03 8.08 7.64 7.37 6.21
Net Income Per Share
3.03 3.03 3.15 3.13 1.48
Tax Burden
1.01 1.01 1.01 1.01 1.02
Interest Burden
0.72 0.71 0.71 0.71 0.61
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.06 0.00 0.07 0.06 0.09
Stock-Based Compensation to Revenue
<0.01 0.00 0.01 0.01 0.03
Income Quality
1.69 1.69 1.52 1.37 2.83
Currency in USD